4.2 Article

Consistency of self-reported first-degree family history of cancer in a population-based study

Journal

FAMILIAL CANCER
Volume 8, Issue 3, Pages 195-202

Publisher

SPRINGER
DOI: 10.1007/s10689-008-9228-2

Keywords

Cancer family history reporting; Consistency of cancer history; Family history of cancer; First-degree cancer history; Self-reported family; history of cancer

Funding

  1. Susan G. Komen for the Cure [POP 0403033]
  2. Fundo de Incentivo a Pesquisa-FIPE
  3. Hospital de Clinicas de Porto Alegre [04-170]
  4. FAPERGS [PPSUS-II 0700964]
  5. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [00202/03-7]

Ask authors/readers for more resources

The aim of this study was to assess the prevalence and consistency of self-reported family history of cancer among first-degree relatives (FDR) in a population-based study. Women at primary care units (PCU) were submitted to a questionnaire about cancer family history. Consistency of the report was determined by comparing self-reported history at the PCU to data from subsequent genetic evaluations and/or cancer confirmatory documents. Consistency in relation to degree of education, reported tumor type and reported age at cancer diagnosis in FDR was assessed. In 8,881 women interviewed, the prevalence of cancer in an FDR was 25.14% (CI 95%: 24.14; 25.94). Mean age was 40.29 years and most (70.26%) had a parts per thousand currency sign8 years of education. There was a good agreement of self-reported cancer history at the PCU and in subsequent genetic evaluations [Kappa coefficient = 0.76 (P < 0.05)]. Inconsistencies were not related to low literacy (chi (2) = 2.027; P = 0.363). Consistency of the reported information for cancer status, cancer type and age of onset was 92.59%, 85.33% and 92.64%, respectively. The prevalence of cancer history in an FDR was similar to previous reports in other populations. Consistency and reliability of the self-reported information was high, regardless of educational level.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

New insights on familial colorectal cancer type X syndrome

Felipe Antonio de Oliveira Garcia, Edilene Santos de Andrade, Henrique de Campos Reis Galvao, Cristina da Silva Sabato, Natalia Campacci, Andre Escremin de Paula, Adriane Feijo Evangelista, Iara Viana Vidigal Santana, Matias Eliseo Melendez, Rui Manuel Reis, Edenir Inez Palmero

Summary: Family colorectal cancer type X (FCCTX) is a heterogeneous colorectal cancer predisposition syndrome with unknown genetic etiology. This study conducted germline exome sequencing on cancer-affected patients from families at risk for FCCTX, and identified rare and potentially pathogenic variants in known hereditary cancer genes, putative FCCTX candidate genes, and other cancer-related genes. These findings provide important clues for understanding the genetic basis of FCCTX.

SCIENTIFIC REPORTS (2022)

Review Neurosciences

Molecular Mechanisms of ZIKV-Induced Teratogenesis: A Systematic Review of Studies in Animal Models

Julia A. Gomes, Gabriela E. Wachholz, Juliano A. Boquett, Fernanda S. L. Vianna, Lavinia Schuler-Faccini, Lucas R. Fraga

Summary: This systematic review evaluates the molecular mechanisms of Zika virus teratogenesis in animal models. The studies found that Zika virus exposure leads to microcephaly, reduced cortex thickness, and growth restriction in embryos. Commonly altered pathways include upregulated immune response pathways and downregulated pathways involved in neurodevelopment.

MOLECULAR NEUROBIOLOGY (2023)

Article Genetics & Heredity

GM1-gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat

Amanda Bingaman, Christine Waggoner, Sara M. Andrews, Diana Pangonis, Marie Trad, Roberto Giugliani, Ruben Giorgino, Jeanine Jarnes, Rojan Vakili, Victoria Ballard, Holly L. Peay

Summary: GM1-gangliosidosis (GM1) is a rare neurodegenerative disorder that leads to early mortality and progressive decline of physical skills and cerebral functioning. This study is the first to explore the priorities of parents of children with pediatric onset forms of GM1. The study identifies the symptoms most critical to caregivers and provides important insights for the development of patient-focused treatments.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Psychiatry

Impact of the COVID-19 pandemic on the mental health of frontline healthcare workers in a highly affected region in Brazil

Mirian Cohen, Luciane Nascimento Cruz, Ricardo Bertoglio Cardoso, Maria de Fatima Pessoa Militao de Albuquerque, Ulisses Ramos Montarroyos, Wayner Vieira de Souza, Ana Bernarda Ludermir, Maria Rosimery de Carvalho, Julianne Damiana da Silva Vicente, Marcelo Paulino Viegas Filho, Fanny Julia Mireille Cortes, Marina Teixeira de Siqueira Silva, Carla Menezes Cavalcante Almeida, Luana Nepomuceno Gondim Costa Lima, Maria Amelia de Sousa Mascena Veras, Carl Kendall, Ligia Regina Franco Sansigolo Kerr, Celina Maria Turchi Martelli, Suzi Alves Camey

Summary: This study aimed to assess the mental health outcomes and associated factors in healthcare workers treating COVID-19 patients in a severely affected region in Brazil. The results showed a high prevalence of positive screening for mental disorders in nurses, physicians, and nursing technicians, which were influenced by work-related factors and individual susceptibility factors.

BMC PSYCHIATRY (2023)

Article Oncology

RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors

Cintia Regina Niederauer Ramos, Renato Jose Silva Oliveira, Marcela Nunes Rosa, Ariane Stefani Pereira, Renata Barbosa Vahia de Abreu, Andre van Helvoort Lengert, Rui Manuel Reis, Viviane Aline Oliveira Silva, Edenir Inez Palmero, Matias Eliseo Melendez

Summary: RAD50 protein deficiency plays an important role in the response of breast cancer cell lines to PARP inhibitors, and may serve as a good biomarker for predicting PARPi response.

CURRENT CANCER DRUG TARGETS (2023)

Review Biotechnology & Applied Microbiology

Ex vivo gene therapy for lysosomal storage disorders: future perspectives

Edina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, Priscila Keiko Matsumoto Martin, Davi Coe Torres, Roberto Giugliani, Guilherme Baldo

Summary: Lysosomal storage disorders (LSD) are rare genetic diseases caused by mutations in lysosomal function-related genes. Gene therapy is a promising approach for LSD due to their monogenic nature and the ability of lysosomal proteins to cross-correct neighboring cells. Ex vivo gene therapy using modified cells from various sources, such as stem cells and hematopoietic precursors, is underway.

EXPERT OPINION ON BIOLOGICAL THERAPY (2023)

Article Pharmacology & Pharmacy

An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis

Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B. Lagler

Summary: Mucopolysaccharidosis (MPS) is a rare group of metabolic diseases with limited treatment options. This study proposes the use of immunomodulatory drugs in innovative individual treatment trials (ITTs) for MPS patients and develops a risk-benefit model for drug evaluation. The decision analysis framework (DAF) includes literature analysis, quantitative risk-benefit assessment, and phenotypic profiling. Four immunomodulatory drugs, adalimumab, abatacept, anakinra, and cladribine, show promise for MPS treatment. This evidence-based model provides a step towards precision medicine in MPS using immunomodulators.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Leukocyte Imbalances in Mucopolysaccharidoses Patients

Nuno Lopes, Maria L. Maia, Catia S. Pereira, Ines Mondragao-Rodrigues, Esmeralda Martins, Rosa Ribeiro, Ana Gaspar, Patricio Aguiar, Paula Garcia, Maria Teresa Cardoso, Esmeralda Rodrigues, Elisa Leao-Teles, Roberto Giugliani, Maria F. F. Coutinho, Sandra Alves, M. Fatima Macedo

Summary: In MPS VI disease patients, there is a decrease in the percentage of natural killer cells and monocytes compared to controls. However, there are no alterations in the percentage of T cells, invariant NKT cells, and B cells in both MPS II and VI disease patients. Interestingly, MPS VI disease patients have a higher frequency of naive T cells and lower memory T cell frequency compared to control subjects.

BIOMEDICINES (2023)

Article Biology

Neanderthal introgression in SCN9A impacts mechanical pain sensitivity

Pierre Faux, Li Ding, Luis Miguel Ramirez-Aristeguieta, J. Camilo Chacon-Duque, Maddalena Comini, Javier Mendoza-Revilla, Macarena Fuentes-Guajardo, Claudia Jaramillo, William Arias, Malena Hurtado, Valeria Villegas, Vanessa Granja, Rodrigo Barquera, Paola Everardo-Martinez, Mirsha Quinto-Sanchez, Jorge Gomez-Valdes, Hugo Villamil-Ramirez, Caio C. Silva de Cerqueira, Tabita Hunemeier, Virginia Ramallo, Rolando Gonzalez-Jose, Lavinia Schuler-Faccini, Maria-Catira Bortolini, Victor Acuna-Alonzo, Samuel Canizales-Quinteros, Giovanni Poletti, Carla Gallo, Francisco Rothhammer, Winston Rojas, Annina B. Schmid, Kaustubh Adhikari, David L. Bennett, Andres Ruiz-Linares

Summary: The Nav1.7 voltage-gated sodium channel plays a key role in nociception. Variants in the SCN9A gene associated with Neanderthal introgression are found to be common in Latin Americans and are associated with lower mechanical pain thresholds.

COMMUNICATIONS BIOLOGY (2023)

Review Oncology

The Relevant Work of Breast Cancer Patient Associations in the Search for Quality Access to Care and Guarantee of Rights in Brazil

Maira Caleffi, Erica Ana Hobold, Gabriel Johnson

Summary: This review article analyzes the structural problems in Brazil's public health system that hinder navigation for breast cancer patients, highlighting the advocacy work of patient associations in increasing cancer prevention awareness, reducing cancer-related stigma, and ensuring access to quality care and treatment.

CURRENT BREAST CANCER REPORTS (2023)

Article Otorhinolaryngology

Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment

Lidia Maria Rebolho Batista Arantes, Renato Jose Silva-Oliveira, Ana Carolina de Carvalho, Matias Eliseo Melendez, Bruna Pereira Sorroche, Renan de Jesus Teixeira, Katiane Tostes, Edenir Inez Palmero, Rui Manuel Reis, Andre Lopes Carvalho

Summary: This study found that the methylation status of MGMT and DAPK has high accuracy in predicting the response of HNSCC cell lines to Afatinib and Allitinib, making them potential predictive biomarkers. These findings hold promise for the development of more personalized and effective treatment approaches for HNSCC patients.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

Retraction Pharmacology & Pharmacy

撤稿声明: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis (Retraction of Vol 15, art no 1565, 2023)

Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B. Lagler

PHARMACEUTICS (2023)

Correction Genetics & Heredity

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants (vol 24, pg 119, 2022)

Hongyan Li, Christoph Engel, Miguel De la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi, Paolo Radice, Mads Thomassen, Thomas V. O. Hansen, Anne-Marie Gerdes, Henriette R. Nielsen, Sandrine M. Caputo, Alberto Zambelli, Ake Borg, Angela Solano, Abigail Thomas, Michael T. Parsons, Antonis C. Antoniou, Goska Leslie, Xin Yang, Georgia Chenevix-Trench, Trinidad Caldes, Ava Kwong, Inge Sokilde Pedersen, Charlotte K. Lautrup, Esther M. John, Mary Beth Terry, John L. Hopper, Melissa C. Southey, Irene L. Andrulis, Marc Tischkowitz, Ramunas Janavicius, Susanne E. Boonen, Lone Kroeldrup, Liliana Varesco, Ute Hamann, Ana Vega, Edenir I. Palmero, Judy Garber, Marco Montagna, Christi J. Van Asperen, Lenka Foretova, Mark H. Greene, Tina Selkirk, Pal Moller, Amanda E. Toland, Susan M. Domchek, Paul A. James, Heather Thorne, Diana M. Eccles, Sarah M. Nielsen, Siranoush Manoukian, Barbara Pasini, Maria A. Caligo, Conxi Lazaro, Judy Kirk, Barbara Wappenschmidt, Amanda B. Spurdle, Fergus J. Couch, Rita Schmutzler, David E. Goldgar

GENETICS IN MEDICINE (2022)

Article Oncology

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium

Pal Moller, Toni Seppala, James G. Dowty, Saskia Haupt, Mev Dominguez-Valentin, Lone Sunde, Inge Bernstein, Christoph Engel, Stefan Aretz, Maartje Nielsen, Gabriel Capella, Dafydd Gareth Evans, John Burn, Elke Holinski-Feder, Lucio Bertario, Bernardo Bonanni, Annika Lindblom, Zohar Levi, Finlay Macrae, Ingrid Winship, John-Paul Plazzer, Rolf Sijmons, Luigi Laghi, Adriana Della Valle, Karl Heinimann, Elizabeth Half, Francisco Lopez-Koestner, Karin Alvarez-Valenzuela, Rodney J. Scott, Lior Katz, Ido Laish, Elez Vainer, Carlos Alberto Vaccaro, Dirce Maria Carraro, Nathan Gluck, Naim Abu-Freha, Aine Stakelum, Rory Kennelly, Des Winter, Benedito Mauro Rossi, Marc Greenblatt, Mabel Bohorquez, Harsh Sheth, Maria Grazia Tibiletti, Leonardo S. Lino-Silva, Karoline Horisberger, Carmen Portenkirchner, Ivana Nascimento, Norma Teresa Rossi, Leandro Apolinario da Silva, Huw Thomas, Attila Zarand, Jukka-Pekka Mecklin, Kirsi Pylvanainen, Laura Renkonen-Sinisalo, Anna Lepisto, Paivi Peltomaki, Christina Therkildsen, Lars Joachim Lindberg, Ole Thorlacius-Ussing, Magnus von Knebel Doeberitz, Markus Loeffler, Nils Rahner, Verena Steinke-Lange, Wolff Schmiegel, Deepak Vangala, Claudia Perne, Robert Hueneburg, Aida Falcon de Vargas, Andrew Latchford, Anne-Marie Gerdes, Ann-Sofie Backman, Carmen Guillen-Ponce, Carrie Snyder, Charlotte K. Lautrup, David Amor, Edenir Palmero, Elena Stoffel, Floor Duijkers, Michael J. Hall, Heather Hampel, Heinric Williams, Henrik Okkels, Jan Lubinski, Jeanette Reece, Joanne Ngeow, Jose G. Guillem, Julie Arnold, Karin Wadt, Kevin Monahan, Leigha Senter, Lene J. Rasmussen, Liselotte P. van Hest, Luigi Ricciardiello, Maija R. J. Kohonen-Corish, Marjolijn J. L. Ligtenberg, Melissa Southey, Melyssa Aronson, Mohd N. Zahary, N. Jewel Samadder, Nicola Poplawski, Nicoline Hoogerbrugge, Patrick J. Morrison, Paul James, Grant Lee, Rakefet Chen-Shtoyerman, Ravindran Ankathil, Rish Pai, Robyn Ward, Susan Parry, Tadeusz Debniak, Thomas John, Thomas van Overeem Hansen, Trinidad Caldes, Tatsuro Yamaguchi, Veronica Barca-Tierno, Pilar Garre, Giulia Martina Cavestro, Juergen Weitz, Silke Redler, Reinhard Buettner, VincentZ Heuveline, John L. Hopper, Aung Ko Win, Noralane Lindor, Steven Gallinger, Loic Le Marchand, Polly A. Newcomb, Jane Figueiredo, Daniel D. Buchanan, Stephen N. Thibodeau, Sanne W. ten Broeke, Eivind Hovig, Sigve Nakken, Marta Pineda, Nuria Duenas, Joan Brunet, Kate Green, Fiona Lalloo, Katie Newton, Emma J. Crosbie, Miriam Mints, Douglas Tjandra, Florencia Neffa, Patricia Esperon, Revital Kariv, Guy Rosner, Walter Hernan Pavicic, Pablo Kalfayan, Giovana Tardin Torrezan, Thiago Bassaneze, Claudia Martin, Gabriela Moslein, Aysel Ahadova, Matthias Kloor, Julian R. Sampson, Mark A. Jenkins

Summary: This study compared the colorectal cancer incidence in carriers of pathogenic variants of the MMR genes in two cohorts. The PLSD cohort, with mandatory colonoscopy surveillance, had higher CRC incidences compared to the retrospective IMRC cohort. Surprisingly, the incidence was not reduced in path_MSH6 carriers. However, the incidence in path_PMS2 carriers was reduced, though not significantly.

HEREDITARY CANCER IN CLINICAL PRACTICE (2022)

Meeting Abstract Biochemistry & Molecular Biology

Familial Colorectal Cancer Type X syndrome: new insights

Felipe A. O. Garcia, Edilene S. de Andrade, Henrique C. R. Galvao, Cristina S. Sabato, Natalia Campacci, Matias E. Melendez, Rui M. Reis, Edenir I. Palmero

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

No Data Available